Metal-free catalysis is transforming future of sustainable pharmaceutical innovation
It offers clear environmental benefits, lower emissions, reduced hazardous material use, and alignment with circular economy goals
It offers clear environmental benefits, lower emissions, reduced hazardous material use, and alignment with circular economy goals
The PLI scheme focuses on incentivizing a strategic shift towards high-value, innovative products such as biologics, complex generics, and specialty formulations
The latest BioE3 policy builds the framework for high-performance biomanufacturing to propel the development and production
Plant-based chemistries have an outsized role to play for the HPC sector by meeting demand for good, gentle, and green products
Rising demands and advancements in eye care drive growth
Through strong industry cooperation, significant investment, and smart policy backing, API manufacturing may become self-reliant
Capital expenditure expected to moderate to Rs. 5.6 billion in FY2025 from an estimated Rs. 7.6 billion in FY2024
The expiry date of almost all strips is rubber stamped vanish in a matter of 3 to 4 months, making the remaining tablets waste for subsequent use before expire date
This exposé embarks on an illuminative journey, unfurling the crucial stratagems imperative for upholding public health, achieved through the unyielding fortress of pharmaceutical quality safeguards
Witnessing sizable consolidation (M& A) activity with Domestic Formulations and Hospitals being two areas wherein maximum M&A has occurred.
Nutrigenomics is the study of how genes and diet (nutrients) interact. Gene variants (genetic differences) predict how an individual’s body will respond to certain nutrients.
Tobacco smoke increases infant morbidity and is fatal to a baby because it damages the baby’s organs
Leading pharma companies are achieving rapid, large-scale performance improvements using a multifaceted approach that realizes short-term gains & builds long-term capabilities at the same time
The next-gen logistics management solutions are making the global supply chains more customer-centric and sustainable
The accelerated use of technology in clinical trials and the shift towards virtual trials is here to stay
The stability is led by healthy demand in the domestic and emerging markets
In India, healthcare has become one of the fastest-growing economic sectors which comprise hospitals, pharma companies, medical equipment and devices, medical tourism, health insurance, clinical trials etc
2022 is going to be the year of opportunities and innovations from the medical industry in India
Subscribe To Our Newsletter & Stay Updated